James M. Cornelius

James M. Cornelius is a declared insider at 7 companies; the most frequent names are Bristol Myers Squibb Co, Mead Johnson Nutrition Co and Chubb Corp. The record holds 251 filings, for trades running from 3 January 2006 to 16 September 2024.

Market trades split into 40 purchases (€8.1M) and 123 sales (€63.5M). No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 27 share grants and 32 option exercises.

The median purchase comes to €76k. For 27 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +3.1%. This is a record of the past, not a forecast.

On 17 September 2024 came the latest disclosure, a transaction in MBX Biosciences, Inc. The last purchase on record was published on 24 August 2015, which is 4,094 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.